Last reviewed · How we verify
Vaccination with Fluval AB influenza vaccine
Vaccination with Fluval AB influenza vaccine is a Biologic drug developed by Fluart Innovative Vaccine Ltd, Hungary. It is currently FDA-approved. Also known as: Influenza, Seasonal vaccine, Vaccination, Prevention.
Fluval AB, an influenza vaccine marketed by Fluart Innovative Vaccine Ltd in Hungary, holds a position in the competitive flu vaccine market with its unique formulation. The key composition patent, set to expire in 2028, provides a significant barrier to entry for generic competitors, enhancing the company's market protection. However, the lack of disclosed revenue and key trial results poses a primary risk, as it limits the ability to assess the vaccine's commercial performance and efficacy relative to competitors.
At a glance
| Generic name | Vaccination with Fluval AB influenza vaccine |
|---|---|
| Also known as | Influenza, Seasonal vaccine, Vaccination, Prevention, Influenza vaccine |
| Sponsor | Fluart Innovative Vaccine Ltd, Hungary |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection (PHASE4)
- Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents (PHASE3)
- Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season (PHASE4)
- Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents (NA)
- Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons (PHASE4)
- Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People (NA)
- A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects (NA)
- Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vaccination with Fluval AB influenza vaccine CI brief — competitive landscape report
- Vaccination with Fluval AB influenza vaccine updates RSS · CI watch RSS
- Fluart Innovative Vaccine Ltd, Hungary portfolio CI
Frequently asked questions about Vaccination with Fluval AB influenza vaccine
What is Vaccination with Fluval AB influenza vaccine?
Who makes Vaccination with Fluval AB influenza vaccine?
Is Vaccination with Fluval AB influenza vaccine also known as anything else?
What development phase is Vaccination with Fluval AB influenza vaccine in?
Related
- Manufacturer: Fluart Innovative Vaccine Ltd, Hungary — full pipeline
- Also known as: Influenza, Seasonal vaccine, Vaccination, Prevention, Influenza vaccine
- Compare: Vaccination with Fluval AB influenza vaccine vs similar drugs
- Pricing: Vaccination with Fluval AB influenza vaccine cost, discount & access